Drug Discovery World

MARCH 7, 2023

Linda Powers, CEO, Northwest Biotherapeutics Powers has served as the Chairman of NW Bio since 2007, and as CEO since 2011. And this is especially true in senior leadership: only one in four C-suite leaders is a woman, and only one in 20 is a woman of colour.” See her interview with Megan Thomas at the Avacta Group Open Day.

International 246

International Science Pharmaceuticals DNA 246

Drug Discovery World

OCTOBER 14, 2022

Wagner, MALDI imaging mass spectrometry: Bridging biology and chemistry in drug development, Bioanalysis, 2011, 3: 2427–2441, [link]. García-Riestra, Application and perspectives of MALDI–TOF mass spectrometry in clinical microbiology laboratories, Microorganisms, 2021, 9: 1539, [link]. Castellino, M.R. Groseclose and D. Ritorto, R.

Synthetic Chemistry 130

Synthetic Chemistry Cell Based Assays Biochemical Assays Analytical Chemistry 130

The Pharma Data

NOVEMBER 5, 2020

Prior to this, he held a position as a director of Analytical Chemistry in Drug Discovery at GlaxoSmithKline. Denner has been with Sarissa since 2011. From 2006 to 2011, Denner served as a senior managing director at Icahn Capital L.P. Most recently, he served as the vice president of Lab Operations at Metabolon.

Analytical Chemistry 40

Analytical Chemistry Pharmaceuticals Small Molecule Therapies 40